$MMATQ
META MATERIALS INC.

2023 Q4 Form 10-Q Financial Statement

#000095017023062493 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $2.323M $2.200M
YoY Change 60.66% -10.42%
Cost Of Revenue $966.6K $790.0K
YoY Change 41.57% 13.39%
Gross Profit $1.356M $1.406M
YoY Change 77.75% -20.05%
Gross Profit Margin 58.38% 63.93%
Selling, General & Admin $7.382M $6.717M
YoY Change -60.85% -62.06%
% of Gross Profit 544.33% 477.58%
Research & Development $3.997M $5.089M
YoY Change -32.78% -18.37%
% of Gross Profit 294.76% 361.8%
Depreciation & Amortization $3.453M $1.700M
YoY Change -11.34% 70.0%
% of Gross Profit 254.61% 120.87%
Operating Expenses $14.83M $16.33M
YoY Change -40.21% -31.76%
Operating Profit -$13.47M -$14.93M
YoY Change -43.96% -32.68%
Interest Expense $1.489M $125.5K
YoY Change 18.26% -6.5%
% of Operating Profit
Other Income/Expense, Net $107.1K $5.651M
YoY Change -105.08% -341.9%
Pretax Income -$79.06M -$9.278M
YoY Change 278.34% -62.15%
Income Tax -$1.889M $540.8K
% Of Pretax Income
Net Earnings -$77.17M -$8.737M
YoY Change 407.39% -64.3%
Net Earnings / Revenue -3322.53% -397.11%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$13.39 -$0.02
COMMON SHARES
Basic Shares Outstanding 490.4M 477.3M
Diluted Shares Outstanding 477.8M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.724M $9.200M
YoY Change -3.64% -71.06%
Cash & Equivalents $9.724M $9.190M
Short-Term Investments
Other Short-Term Assets $5.680M $808.0K
YoY Change 1453.59% -98.97%
Inventory $168.8K $122.3K
Prepaid Expenses $1.477M $2.119M
Receivables $1.824M $1.700M
Other Receivables $0.00 $8.501K
Total Short-Term Assets $17.40M $15.99M
YoY Change -23.04% -85.81%
LONG-TERM ASSETS
Property, Plant & Equipment $19.80M $46.02M
YoY Change -53.6% 33.25%
Goodwill
YoY Change
Intangibles $18.03M $51.26M
YoY Change -67.98% 0.45%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $37.83M $105.8M
YoY Change -90.21% -71.41%
TOTAL ASSETS
Total Short-Term Assets $17.40M $15.99M
Total Long-Term Assets $37.83M $105.8M
Total Assets $55.23M $121.8M
YoY Change -86.49% -74.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.27M $10.70M
YoY Change -38.48% -16.52%
Accrued Expenses $9.884M $2.100M
YoY Change 922.02% 142.91%
Deferred Revenue $1.055M $1.481M
YoY Change 44.36% 137.46%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.785M $709.0K
YoY Change 269.3% -4.55%
Total Short-Term Liabilities $23.58M $16.71M
YoY Change 19.87% -80.91%
LONG-TERM LIABILITIES
Long-Term Debt $2.923M $2.948M
YoY Change -4.81% 37.9%
Other Long-Term Liabilities $6.784M $6.900M
YoY Change 62.53% 87.42%
Total Long-Term Liabilities $9.707M $2.948M
YoY Change 216.11% 37.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.58M $16.71M
Total Long-Term Liabilities $9.707M $2.948M
Total Liabilities $33.29M $28.42M
YoY Change 9.68% -69.71%
SHAREHOLDERS EQUITY
Retained Earnings -$609.0M -$530.6M
YoY Change 193.49% 175.94%
Common Stock $636.4M $628.5M
YoY Change 7.63% 6.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.94M $93.33M
YoY Change
Total Liabilities & Shareholders Equity $55.23M $121.8M
YoY Change -86.49% -74.77%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$77.17M -$8.737M
YoY Change 407.39% -64.3%
Depreciation, Depletion And Amortization $3.453M $1.700M
YoY Change -11.34% 70.0%
Cash From Operating Activities -$5.129M -$11.20M
YoY Change -62.64% -42.6%
INVESTING ACTIVITIES
Capital Expenditures $411.1K $1.470M
YoY Change -94.6% -148.94%
Acquisitions
YoY Change
Other Investing Activities -$430.00 $6.080M
YoY Change -100.02%
Cash From Investing Activities -$411.5K $4.620M
YoY Change -92.74% -253.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.565M 2.510M
YoY Change 68777.6% -1092.09%
NET CHANGE
Cash From Operating Activities -5.129M -11.20M
Cash From Investing Activities -411.5K 4.620M
Cash From Financing Activities 5.565M 2.510M
Net Change In Cash 24.88K -4.070M
YoY Change -100.13% -82.13%
FREE CASH FLOW
Cash From Operating Activities -$5.129M -$11.20M
Capital Expenditures $411.1K $1.470M
Free Cash Flow -$5.540M -$12.67M
YoY Change -74.04% -23.26%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001431959
CY2023Q3 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36247
dei Entity Registrant Name
EntityRegistrantName
Meta Materials Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-3237581
dei Entity Address Address Line1
EntityAddressAddressLine1
60 Highfield Park Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Dartmouth
dei Entity Address State Or Province
EntityAddressStateOrProvince
NS
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
B3A 4R9
dei City Area Code
CityAreaCode
902
dei Local Phone Number
LocalPhoneNumber
482-5729
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MMAT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
490414607
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9189994
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10090858
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1000740
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1720613
CY2023Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1688711
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
902718
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
2211900
CY2023Q3 us-gaap Inventory Net
InventoryNet
122306
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3979055
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8501
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8461
CY2023Q3 us-gaap Assets Current
AssetsCurrent
15989307
CY2022Q4 us-gaap Assets Current
AssetsCurrent
22604676
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51256980
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56313317
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46015506
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8410263
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5576824
CY2023Q3 mmat Subscription Receivable Noncurrent
SubscriptionReceivableNoncurrent
82645
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
CY2023Q3 us-gaap Assets
Assets
121754701
CY2022Q4 us-gaap Assets
Assets
408917982
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10700047
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16694211
CY2023Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
661405
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
709015
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1481487
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
730501
CY2023Q3 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
807095
CY2022Q4 mmat Deferred Government Assistance Current
DeferredGovernmentAssistanceCurrent
799490
CY2023Q3 mmat Funding Obligation Current
FundingObligationCurrent
961538
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1391757
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
967126
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16712344
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
19674554
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
433717
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
479808
CY2023Q3 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
387714
CY2022Q4 mmat Deferred Government Assistance Amount Noncurrent
DeferredGovernmentAssistanceAmountNoncurrent
319017
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1832221
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3253985
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6110144
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3375031
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
180705
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2948254
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2023Q3 us-gaap Liabilities
Liabilities
28424394
CY2022Q4 us-gaap Liabilities
Liabilities
30353829
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
485339440
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
485339440
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
362247867
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
362247867
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
463516
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
340425
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
628002196
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
590962866
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4555010
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5242810
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530580395
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-207496328
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
93330307
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
121754701
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
408917982
CY2023Q3 us-gaap Revenues
Revenues
2200162
CY2022Q3 us-gaap Revenues
Revenues
2456012
us-gaap Revenues
Revenues
5642945
us-gaap Revenues
Revenues
8754434
CY2023Q3 mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
750969
CY2022Q3 mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
514312
mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
2096615
mmat Cost Of Goods And Service Excluding Depreciation And Amortization And Stock Based Compensation
CostOfGoodsAndServiceExcludingDepreciationAndAmortizationAndStockBasedCompensation
1921845
CY2023Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
9980
CY2022Q3 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
14639
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
37323
us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
55298
CY2023Q3 mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
32744
CY2022Q3 mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
167779
mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
173713
mmat Stock Based Compensation Expense Included In Cost Of Sales
StockBasedCompensationExpenseIncludedInCostOfSales
376250
CY2023Q3 us-gaap Gross Profit
GrossProfit
1406469
CY2022Q3 us-gaap Gross Profit
GrossProfit
1759282
us-gaap Gross Profit
GrossProfit
3335294
us-gaap Gross Profit
GrossProfit
6401041
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
835405
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
874315
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3922990
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2842165
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5881598
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13832656
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18564304
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35039472
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5088556
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4967997
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15208926
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12174718
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3441812
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1871163
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10034834
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5322172
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
278539
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2389749
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-670108
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10250149
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
809002
us-gaap Restructuring Charges
RestructuringCharges
2278151
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282173053
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
16334912
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
23935880
us-gaap Operating Expenses
OperatingExpenses
331512150
us-gaap Operating Expenses
OperatingExpenses
65628676
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14928443
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-22176598
us-gaap Operating Income Loss
OperatingIncomeLoss
-328176856
us-gaap Operating Income Loss
OperatingIncomeLoss
-59227635
CY2023Q3 us-gaap Interest Expense
InterestExpense
125482
CY2022Q3 us-gaap Interest Expense
InterestExpense
134205
us-gaap Interest Expense
InterestExpense
243002
us-gaap Interest Expense
InterestExpense
440694
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
78602
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
35691
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-319925
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
44964
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1526356
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-2259324
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
319355
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3091919
CY2023Q3 us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
6750195
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
6750195
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
473638
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
21908
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-844487
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1324528
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5650597
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2335930
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5662136
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4812177
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9277846
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24512528
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-322514720
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-64039812
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
540843
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-37208
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1455653
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-147193
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8737003
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-24475320
us-gaap Net Income Loss
NetIncomeLoss
-321059067
us-gaap Net Income Loss
NetIncomeLoss
-63892619
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-74022
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4413860
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
687800
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6565154
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-74022
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4413860
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
687800
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6565154
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8811025
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28889180
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-320371267
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70457773
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
477808766
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
477808766
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362260641
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
362260641
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
432883181
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
432883181
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
316661487
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
316661487
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
100249885
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8737003
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-74022
CY2023Q3 mmat Common Stock Issued During Period Value
CommonStockIssuedDuringPeriodValue
2567156
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1078552
CY2023Q3 mmat Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
91558
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
311285
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
93330307
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
415125132
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-24475320
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4413860
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
32472
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2557530
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
388825954
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
378564153
us-gaap Net Income Loss
NetIncomeLoss
-321059067
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
687800
mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
38891964
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4400783
mmat Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
803089
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-156849
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
93330307
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
334708115
us-gaap Net Income Loss
NetIncomeLoss
-63892619
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6565154
mmat Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
50000000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3680666
mmat Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
507367
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
67122512
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10626399
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
388825954
us-gaap Net Income Loss
NetIncomeLoss
-321059067
us-gaap Net Income Loss
NetIncomeLoss
-63892619
mmat Noncash Finance Income Expense
NoncashFinanceIncomeExpense
-710797
mmat Noncash Finance Income Expense
NoncashFinanceIncomeExpense
12433
us-gaap Paid In Kind Interest
PaidInKindInterest
281128
us-gaap Paid In Kind Interest
PaidInKindInterest
419684
mmat Non Cash Interest Income
NonCashInterestIncome
979997
mmat Non Cash Lease Expense
NonCashLeaseExpense
1443293
mmat Non Cash Lease Expense
NonCashLeaseExpense
1212415
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282173053
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1455653
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-147193
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10072157
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5377470
us-gaap Inventory Write Down
InventoryWriteDown
339838
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1799977
mmat Unrealized Loss Gain Net Excluding Foreign Currency Exchange
UnrealizedLossGainNetExcludingForeignCurrencyExchange
81142
mmat Unrealized Loss Gain Net Excluding Foreign Currency Exchange
UnrealizedLossGainNetExcludingForeignCurrencyExchange
-2843223
mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
702782
mmat Adjustments In Contract With Customer Liability
AdjustmentsInContractWithCustomerLiability
-199785
mmat Government Assistance
GovernmentAssistance
3047
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
783
us-gaap Gain Loss On Sale Of Notes Receivable
GainLossOnSaleOfNotesReceivable
6750195
us-gaap Share Based Compensation
ShareBasedCompensation
-496397
us-gaap Share Based Compensation
ShareBasedCompensation
9763627
mmat Non Cash Consulting Expense
NonCashConsultingExpense
862771
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3786778
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
4739841
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37086204
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48516511
mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
7962480
mmat Payments For Proceeds From Property And Equipment
PaymentsForProceedsFromPropertyAndEquipment
11975134
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
39140
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1620281
mmat Proceeds From Below Market Capital Government Loan
ProceedsFromBelowMarketCapitalGovernmentLoan
256240
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1000000
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
6083333
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3486906
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-622907
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13802619
mmat Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
38891964
mmat Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
50000000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3375783
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3680666
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
293450
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
467767
mmat Proceeds From Stock Option And Warrants Exercises
ProceedsFromStockOptionAndWarrantsExercises
803088
mmat Proceeds From Stock Option And Warrants Exercises
ProceedsFromStockOptionAndWarrantsExercises
507367
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36025819
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46358934
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1683292
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15960196
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11811471
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47434472
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62555
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-429356
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10190734
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31044920
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
981767
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
536778
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1434186
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
142378
mmat Common Stock Issuance Costs In Accrued Liabilities Or Accounts Payable
CommonStockIssuanceCostsInAccruedLiabilitiesOrAccountsPayable
1025000
mmat Number Of Active Patent Documents
NumberOfActivePatentDocuments
500
mmat Number Of Patents Have Issued
NumberOfPatentsHaveIssued
300
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassification of Prior Year Presentation</span></p><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. An adjustment has been made to the condensed consolidated interim statement of operations and comprehensive loss.</span></p>
us-gaap Substantial Doubt About Going Concern Managements Evaluation
SubstantialDoubtAboutGoingConcernManagementsEvaluation
Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances.
us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
us-gaap Net Income Loss
NetIncomeLoss
-321100000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282200000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
79100000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530600000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
494883
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
490077
CY2023Q3 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
10942
CY2022Q4 us-gaap Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
11345
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
45978
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
51589
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
43155
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
42058
CY2023Q3 mmat Inventory Provision
InventoryProvision
472652
CY2022Q4 mmat Inventory Provision
InventoryProvision
127042
CY2023Q3 us-gaap Inventory Net
InventoryNet
122306
CY2022Q4 us-gaap Inventory Net
InventoryNet
468027
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2119071
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2835660
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
807961
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
365583
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1052023
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4000856
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3979055
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7202099
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
61056703
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52954295
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15041197
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10279596
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46015506
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42674699
CY2023Q3 us-gaap Depreciation
Depreciation
1700000
CY2022Q3 us-gaap Depreciation
Depreciation
1000000
us-gaap Depreciation
Depreciation
4800000
us-gaap Depreciation
Depreciation
2600000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
66063869
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
65811004
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14806889
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9497687
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
51256980
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
56313317
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5300000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
CY2022Q4 us-gaap Goodwill
Goodwill
281748466
mmat Goodwill Impairment
GoodwillImpairment
282173053
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
424587
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
282200000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
3657269
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
3553955
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
709015
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
483226
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2948254
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3070729
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
mmat Event Market Price Description
EventMarketPriceDescription
“Event Market Price” means, with respect to any Share Combination Event Date, the quotient determined by dividing (x) the sum of the volume weighted average price of the shares of common stock for each of the five trading days following such Share Combination Event divided by (y) five.
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.8
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M21D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17611251
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3376143
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.21
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12806810
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.97
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2635161
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.27
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21529216
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y2M15D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
78827
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15904659
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.62
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M10D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
47615
CY2023Q3 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
21529216
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15904659
CY2022Q4 mmat Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesOutstanding
33595044
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24327577
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8568
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0385
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y14D
CY2023Q3 mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
-500000
CY2022Q3 mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
-37208
mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
-1500000
mmat Deferred Income Tax Recovery
DeferredIncomeTaxRecovery
-100000
CY2023Q3 mmat Net Loss
NetLoss
-8737003
CY2022Q3 mmat Net Loss
NetLoss
-24475320
mmat Net Loss
NetLoss
-321059067
mmat Net Loss
NetLoss
-63892619
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
2025000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8737003
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24475320
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-323084067
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-63892619
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
477808766
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
362260641
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
432883181
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
316661487
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
477808766
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
362260641
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
432883181
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
316661487
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.2
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.2
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155687486
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82204349
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
155687486
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
82204349
mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
0
mmat Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
-145704
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-28446
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31543
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
5435
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
385541
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3262598
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3280831
mmat Increase Decrease In Trade Payables And Accruals
IncreaseDecreaseInTradePayablesAndAccruals
-6622388
mmat Increase Decrease In Trade Payables And Accruals
IncreaseDecreaseInTradePayablesAndAccruals
-445489
us-gaap Restructuring Costs
RestructuringCosts
661405
us-gaap Restructuring Costs
RestructuringCosts
0
mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
261
mmat Increase Decrease In Due From To Related Parties Current
IncreaseDecreaseInDueFromToRelatedPartiesCurrent
2105
mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0
mmat Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
231
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1111143
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-739805
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
3786778
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
4739841
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2200162
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2456012
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5642945
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8754434
CY2021Q4 mmat Development Contract Value
DevelopmentContractValue
41500000
CY2021 mmat Development Contract Period Maximum
DevelopmentContractPeriodMaximum
P5Y
CY2023Q3 mmat Development Contract Value
DevelopmentContractValue
2100000
CY2023Q3 mmat Development Contract Value
DevelopmentContractValue
6200000
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
580792
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
440649
us-gaap Operating Lease Expense
OperatingLeaseExpense
1707358
us-gaap Operating Lease Expense
OperatingLeaseExpense
1326370
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
52373
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
199637
us-gaap Short Term Lease Cost
ShortTermLeaseCost
221190
us-gaap Short Term Lease Cost
ShortTermLeaseCost
358877
CY2023Q3 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
199123
CY2022Q3 mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
59678
mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
489826
mmat Variable And Other Lease Expense
VariableAndOtherLeaseExpense
174021
CY2023Q3 us-gaap Lease Cost
LeaseCost
832288
CY2022Q3 us-gaap Lease Cost
LeaseCost
699964
us-gaap Lease Cost
LeaseCost
2418374
us-gaap Lease Cost
LeaseCost
1859268
CY2021Q1 mmat Revenue Related To Patents Purchased
RevenueRelatedToPatentsPurchased
100000
us-gaap Royalty Expense
RoyaltyExpense
0
us-gaap Royalty Expense
RoyaltyExpense
0
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
408458
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1936202
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1712612
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1570449
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1151683
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1160800
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3770240
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11710444
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4208543
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7501901
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1391757
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6110144
us-gaap Restructuring And Related Activities Initiation Date
RestructuringAndRelatedActivitiesInitiationDate
2023-06-06
us-gaap Restructuring Charges
RestructuringCharges
2300000
CY2023Q3 mmat Provisions For Severance Payments
ProvisionsForSeverancePayments
700000
us-gaap Severance Costs1
SeveranceCosts1
2300000
us-gaap Payments For Restructuring
PaymentsForRestructuring
1600000
CY2021Q1 mmat Number Of Patents
NumberOfPatents
6
CY2022Q1 mmat Percentage Of Net Profit Equivalent Of Allocate Bonus Pool
PercentageOfNetProfitEquivalentOfAllocateBonusPool
0.50

Files In Submission

Name View Source Status
0000950170-23-062493-index-headers.html Edgar Link pending
0000950170-23-062493-index.html Edgar Link pending
0000950170-23-062493.txt Edgar Link pending
0000950170-23-062493-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mmat-20230930.htm Edgar Link pending
mmat-20230930.xsd Edgar Link pending
mmat-ex31_1.htm Edgar Link pending
mmat-ex31_2.htm Edgar Link pending
mmat-ex32_1.htm Edgar Link pending
mmat-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mmat-20230930_cal.xml Edgar Link unprocessable
mmat-20230930_pre.xml Edgar Link unprocessable
mmat-20230930_def.xml Edgar Link unprocessable
mmat-20230930_lab.xml Edgar Link unprocessable
mmat-20230930_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending